Mach7 Technologies and 3D Medical Complete Merger
|
By HospiMedica International staff writers Posted on 21 Apr 2016 |
|
Mach7 Technologies (Burlington, VT, USA) and 3D Medical (3DM; Port Melbourne, VIC, Australia) have formed a combined company poised to bring advanced medical image management solutions to customers worldwide.
As a result, 3DM, a medical-specific three dimensional (3D) printing, holographic projection, and data integrations provider, is now a wholly- owned subsidiary of Mach7 Technologies, with the combined company renamed Mach7 Technologies Limited. The merger is designed to expand the international market for the enterprise imaging and 3D printing capabilities of the company, which include 3D medical printing; EchoPixel holographic projection technology; and GestSure surgery image control.
Mach7 Technologies provides an enterprise platform that delivers complete image management with rapid record identification, integration, synchronization and routing, advanced clinical viewing, and optimized, vendor-neutral archiving. Under the terms of the merger, Mach7 Technologies will maintain its US headquarters for product development, professional services, sales and marketing, with the Australian 3DM offices in charge of expanding sales and marketing efforts throughout Australia, New Zealand, and Western Europe.
“We will remain a nimble company focused on providing the most innovative enterprise imaging platform in the world. Access to new capital will enable us to surpass business and product roadmap goals in a shorter time frame and to better serve our customers,” said Albert Liong, CEO of Mach7 Technologies Limited. “Mach7 has enjoyed substantial growth in recent years, and we feel this will be enhanced with access to the public capital market. Australian investors appreciate world leading healthcare technology, and we look forward to this new phase as we continue to build our global presence.”
“We are delighted to have secured an agreement to bring our companies together; we have enjoyed a close working relationship with Mach7 and admire their outstanding success in the USA and Asia,” said Dr. Nigel Finch, chairman of 3DM. “The transaction will drive earnings and transform the combined entity into a global operation, allowing significant opportunities to scale 3DM’s value-adding data activities to leading healthcare institutions globally.”
Related Links:
Mach7 Technologies
3D Medical
As a result, 3DM, a medical-specific three dimensional (3D) printing, holographic projection, and data integrations provider, is now a wholly- owned subsidiary of Mach7 Technologies, with the combined company renamed Mach7 Technologies Limited. The merger is designed to expand the international market for the enterprise imaging and 3D printing capabilities of the company, which include 3D medical printing; EchoPixel holographic projection technology; and GestSure surgery image control.
Mach7 Technologies provides an enterprise platform that delivers complete image management with rapid record identification, integration, synchronization and routing, advanced clinical viewing, and optimized, vendor-neutral archiving. Under the terms of the merger, Mach7 Technologies will maintain its US headquarters for product development, professional services, sales and marketing, with the Australian 3DM offices in charge of expanding sales and marketing efforts throughout Australia, New Zealand, and Western Europe.
“We will remain a nimble company focused on providing the most innovative enterprise imaging platform in the world. Access to new capital will enable us to surpass business and product roadmap goals in a shorter time frame and to better serve our customers,” said Albert Liong, CEO of Mach7 Technologies Limited. “Mach7 has enjoyed substantial growth in recent years, and we feel this will be enhanced with access to the public capital market. Australian investors appreciate world leading healthcare technology, and we look forward to this new phase as we continue to build our global presence.”
“We are delighted to have secured an agreement to bring our companies together; we have enjoyed a close working relationship with Mach7 and admire their outstanding success in the USA and Asia,” said Dr. Nigel Finch, chairman of 3DM. “The transaction will drive earnings and transform the combined entity into a global operation, allowing significant opportunities to scale 3DM’s value-adding data activities to leading healthcare institutions globally.”
Related Links:
Mach7 Technologies
3D Medical
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Hybrid Arch Device
Neo EDE
New
X-Ray Generator
Advantage Plus Generators
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Critical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
Surgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
